Following a resubmission
Emtricitabine (Emtriva®) is accepted for use within NHS Scotland for the treatment of HIV-1 infected adults in combination with other antiretroviral agents. It should be prescribed only by HIV specialists.
This indication is based on studies in treatment-naïve patients and treatment-experienced patients with stable virological control in whom, as part of antiretroviral therapy (ART) regimens, it has shown virological responses comparable with other ART. There is no experience of use in patients who are failing their current regimen or who have failed multiple regimens.
Download detailed advice52KB (PDF)
- Medicine name:
- Emtricitabine 200 mg hard capsules (Emtriva®)
- SMC ID:
- HIV-1 infected adults in combination with other antiretroviral agents
- Pharmaceutical company
- Gilead Sciences Ltd
- BNF chapter
- Submission type
- Date advice published
- 13 February 2006